Evommune Inc share price logo

Evommune Inc Share Price

NYSE: EVMN

Small Cap

$18.84

-1.39

(-6.87%)

as on

Evommune Inc Stock Performance

as on November 8, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $18.45
    $24.03
    downward going graph

    2.07%

    Downside

    27.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Evommune Inc share price movements today

Previous Close
$20.23
Open
$20.83
Volume
370.4K
Day's Low - High
$18.45 - $24.03

Evommune Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Evommune Inc Stock Fundamentals & Key Indicators

Check Evommune Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Evommune Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Evommune Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Evommune Inc image
Evommune Inc
NA$-NANA0.00%

About Evommune Inc

Evommune, Inc. is a clinical-stage biotechnology company developing therapies that target key drivers of chronic inflammatory diseases. The Company’s initial clinical development programs are focusing on chronic spontaneous urticaria (CSU), atopic dermatitis (AD) and ulcerative colitis (UC). Its product candidates include EVO756 and EVO30. The Company's advanced clinical-stage product candidate, EVO756, is a potent and highly selective oral small molecule antagonist of MRGPRX2, a receptor predominantly found on mast cells and peripheral sensory neurons, which is initially being evaluated in Phase II trials for the treatment of CSU and AD. Its second clinical-stage product candidate, EVO301, is a long-acting fusion protein consisting of an IL-18 binding protein (BP) and an anti-serum albumin Fab-associated (SAFA) domain, which is being evaluated in Phase II trials for the treatment of AD and UC.
OrganisationEvommune Inc
E-voting on sharesClick here to vote

FAQs

What is Evommune Inc share price today?

Evommune Inc share price today is $18.84 as on at the close of the market. Evommune Inc share today touched a day high of $24.03 and a low of $18.45.

What is the 52 week high and 52 week low for Evommune Inc share?

Evommune Inc share touched a 52 week high of $ on and a 52 week low of $ on . Evommune Inc stock price today i.e. is closed at $18.84,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Evommune Inc Stock (EVMN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evommune Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evommune Inc Shares that will get you 0.0796 shares as per Evommune Inc share price of $18.84 per share as on November 8, 2025 at 2:29 am IST.

What is the minimum amount required to buy Evommune Inc Stock (EVMN) from India?

Indian investors can start investing in Evommune Inc (EVMN) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Evommune Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Evommune Inc share’s latest price of $18.84 as on November 8, 2025 at 2:29 am IST, you will get 0.5308 shares of Evommune Inc. Learn more about fractional shares .